מימפרה 90 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

CINACALCET HYDROCHLORIDE 90 MG

Disponible depuis:

AMGEN EUROPE B.V.

Code ATC:

H05BX01

forme pharmaceutique:

FILM COATED TABLETS

Mode d'administration:

PER OS

Fabriqué par:

AMGEN EUROPE B.V., NETHERLANDS

Groupe thérapeutique:

CINACALCET

indications thérapeutiques:

Treatment of secondary hyperparathyrodism (HPT) in patients with end-dtage renal disease (ESRD) on maintenance dialysis therapy. Mimpara may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma.

Date de l'autorisation:

2012-10-01